SciClone Pharmaceuticals, Inc. Reconfirms Earnings Guidance for the Year 2014; Provides Sales Revenue Guidance for the Year 2015
January 06, 2015 at 04:30 pm IST
SciClone Pharmaceuticals, Inc. reconfirmed earnings guidance for the year 2014 and provided sales revenue guidance for the year 2015. For the year 2014, the company reconfirmed expected sales revenue of $130 million to $135 million, representing an approximate 30% increase of its core business revenue over 2013. The company reconfirmed non-GAAP EPS of $0.64 to $0.68, as a result of reduced marketing and general and administrative expenses.
For the year 2015, the company anticipates sales revenue of $153 million to $158 million, representing an approximately 17% increase over 2014.